Altice USA to Hold Conference Call to Discuss Q2 2024 Results
Altice USA to Hold Conference Call to Discuss Q2 2024 Results
Altice USA (NYSE: ATUS) will host a conference call on Thursday, August 1, 2024 at 8:30 a.m. ET to discuss financial and operating results for the second quarter ended June 30, 2024. A press release reporting the results will be issued at 7:00 a.m. ET.
The call will be led by Dennis Mathew, Chairman and CEO, and Marc Sirota, CFO.
Dial-in Access Telephone Numbers:
Participant Dial-In: 877-404-9653 / +1 201-689-8856
A live webcast of the presentation will be available on the following website: here.
The presentation for the conference call will be made available prior to the call on the company’s investor relations website: https://investors.alticeusa.com.
About Altice USA
Altice USA (NYSE: ATUS) is one of the largest broadband communications and video services providers in the United States, delivering broadband, video, mobile, proprietary content and advertising services to approximately 4.7 million residential and business customers across 21 states through its Optimum brand. The Company operates Optimum Media, an advanced advertising and data business, which provides audience-based, multiscreen advertising solutions to local, regional and national businesses and advertising clients. Altice USA also offers hyper-local and international news through its News 12 and i24NEWS networks.
Investor Relations
John Hsu +1 (917) 405-2097 / john.hsu@alticeusa.com
Sarah Freedman: +1 (631) 660-8714 / sarah.freedman@alticeusa.com
Communications
Lisa Anselmo: +1 (516) 279-9461 / lisa.anselmo@alticeusa.com
Janet Meahan: +1 (516) 519-2353 / janet.meahan@alticeusa.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20240626659610/en/
-
Markets Brief: US Jobs Report in View as Q3 Begins
-
Q3 2024 Stock Market Outlook: Is the AI Stock Trade Over?
-
Ian Bremmer: 4 Big Geopolitical Risks to Watch
-
What’s Happening In the Markets This Week
-
Obesity Drug Stocks: Why It Will Be ‘Exceptionally Difficult’ to Dethrone Eli Lilly and Novo Nordisk
-
What Does Chipotle’s Stock Split Mean for Investors?
-
5 Stocks to Buy Before the Fed Cuts Interest Rates in 2024
-
Markets Brief: Inflation Is Back In the Spotlight
-
10 Top Dividend Stocks for 2024
-
Finding Small-Cap Stock Opportunities In a Big-Cap World
-
The 10 Best Companies to Invest in Now
-
Nike Earnings: Dim Sales Outlook Slams Shares, but Patient Investors Could Be Rewarded
-
2 Top E-Commerce Stock Picks
-
Our Top Pick for Investing in US Renewable Energy
-
Micron Earnings: We Raise Our DRAM Forecast and Valuation Behind Stronger Pricing Assumptions
-
10 Undervalued Wide-Moat Stocks